Search Results - "Nieto, Yago L"

Intratumoral heterogeneity: Role of differentiation in a potentially lethal phenotype of testicular cancer by Tu, Shi‐Ming, Bilen, Mehmet Asim, Hess, Kenneth R., Broaddus, Russell R., Kopetz, Scott, Wei, Chongjuan, Pagliaro, Lance C., Karam, Jose A., Ward, John F., Wood, Christopher G., Rao, Priya, Tu, Zachary H., General, Rosale, Chen, Adrienne H., Nieto, Yago L., Yeung, Sai‐ching J., Lin, Sue‐Hwa, Logothetis, Christopher J., Pisters, Louis L.

“…BACKGROUND Intratumoral heterogeneity presents a major obstacle to the widespread implementation of precision medicine. The authors assessed the origin of…”
Get full text

Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood-Derived NK Cells Facilitates CAR-like Responses Against CD30 + Malignancies by Kerbauy, Lucila N, Marin, Nancy D, Kaplan, Mecit, Banerjee, Pinaki P, Berrien-Elliott, Melissa M, Becker-Hapak, Michelle, Basar, Rafet, Foster, Mark, Garcia Melo, Luciana, Neal, Carly C, McClain, Ethan, Daher, May, Nunez Cortes, Ana Karen, Desai, Sweta, Inng Lim, Francesca Wei, Mendt, Mayela Carolina, Schappe, Timothy, Li, Li, Shaim, Hila, Shanley, Mayra, Ensley, Emily L, Uprety, Nadima, Wong, Pamela, Liu, Enli, Ang, Sonny O, Cai, Rong, Nandivada, Vandana, Mohanty, Vakul, Miao, Qi, Shen, Yifei, Baran, Natalia, Fowlkes, Natalie W, Chen, Ken, Muniz-Feliciano, Luis, Champlin, Richard E, Nieto, Yago L, Koch, Joachim, Treder, Martin, Fischer, Wolfgang, Okamoto, Oswaldo Keith, Shpall, Elizabeth J, Fehniger, Todd A, Rezvani, Katayoun

“…Natural killer (NK)-cell recognition and function against NK-resistant cancers remain substantial barriers to the broad application of NK-cell immunotherapy…”
Get full text

Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies by Ramos, Carlos A, Saliba, Rima M, de Padua, Leandro, Khorshid, Ola, Shpall, Elizabeth J, Giralt, Sergio, Patah, Poliana A, Hosing, Chitra M, Popat, Uday R, Rondon, Gabriela, Khouri, Issa F, Nieto, Yago L, Champlin, Richard E, de Lima, Marcos

“…1 Department of Stem Cell Transplantation and Cellular Therapy, the University of Texas M. D. Anderson Cancer Center, Houston, TX, USA 2 Departamento de…”
Get full text

The survival outcome of patients with relapsed/refractory peripheral T‐cell lymphoma‐not otherwise specified and angioimmunoblastic T‐cell lymphoma by Chihara, Dai, Fanale, Michelle A., Miranda, Roberto N., Noorani, Mansoor, Westin, Jason R., Nastoupil, Loretta J., Hagemeister, Fredrick B., Fayad, Luis E., Romaguera, Jorge E., Samaniego, Felipe, Turturro, Francesco, Lee, Hun J., Neelapu, Sattva S., Rodriguez, M. Alma, Wang, Michael, Fowler, Nathan H., Davis, Richard E., Medeiros, L. Jeffrey, Hosing, Chitra, Nieto, Yago L., Oki, Yasuhiro

“…Summary Survival outcome of patients with peripheral T‐cell lymphoma‐not otherwise specified (PTCL‐NOS) and angioimmunoblastic T‐cell lymphoma (AITL) who…”
Get full text

CD30 expression is frequently decreased in relapsed classic Hodgkin lymphoma after anti‐CD30 CAR T‐cell therapy by Marques‐Piubelli, Mario L., Kim, Do Hwan, Medeiros, L. Jeffrey, Lu, Wei, Khan, Khaja, Gomez‐Bolanos, Lorena Isabel, Rodriguez, Saxon, Parra, Edwin R., Ok, Chi Young, Aradhya, Akanksha, Solis, Luisa M, Nieto, Yago L., Steiner, Raphael, Ahmed, Sairah, Vega, Francisco

“…Chimeric antigen receptor (CAR) T‐cells anti‐CD30 is an innovative therapeutic option that has been used to treat cases of refractory/relapsed (R/R) classic…”
Get full text

A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma by Merrill, Mwanasha H, Dahi, Parastoo B, Redd, Robert A, McDonough, Mikaela M, Chen, Yi-Bin, DeFilipp, Zachariah, Herrera, Alex F, Fisher, David C, LaCasce, Ann S, Odejide, Oreofe O, Ng, Samuel Y, Jacobson, Caron A, Merryman, Reid W, Kim, Austin I, Nieto, Yago L, Sauter, Craig S, Shah, Gunjan L, Zain, Jasmine M, Armand, Philippe, Jacobsen, Eric D

“…Autologous stem cell transplantation (ASCT) is often used as consolidation for several subtypes of peripheral T-cell lymphoma (PTCL) in first remission…”
Get full text

Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: A CIBMTR report by Schriber, Jeffrey R., Hari, Parameswaran N., Ahn, Kwang Woo, Fei, Mingwei, Costa, Luciano J., Kharfan‐Dabaja, Mohamad A., Angel‐Diaz, Miguel, Gale, Robert P., Ganguly, Siddharatha, Girnius, Saulius K., Hashmi, Shahrukh, Pawarode, Attaphol, Vesole, David H., Wiernik, Peter H., Wirk, Baldeep M., Marks, David I., Nishihori, Taiga, Olsson, Richard F., Usmani, Saad Z., Mark, Tomer M., Nieto, Yago L., D'Souza, Anita

“…BACKGROUND Race/ethnicity remains an important barrier in clinical care. The authors investigated differences in the receipt of autologous hematopoietic cell…”
Get full text

Inpatient vs outpatient autologous hematopoietic stem cell transplantation for multiple myeloma by Shah, Nina, Cornelison, A. Megan, Saliba, Rima, Ahmed, Sairah, Nieto, Yago L., Bashir, Qaiser, Parmar, Simrit, Hosing, Chitra, Popat, Uday, Shpall, Elizabeth J., Champlin, Richard E., Qazilbash, Muzaffar

“…Background High‐dose chemotherapy and autologous hematopoietic stem cell transplantation (auto‐HCT) are commonly performed for multiple myeloma (MM) patients…”
Get full text

Conditioning with busulfan plus melphalan versus melphalan alone before autologous haemopoietic cell transplantation for multiple myeloma: an open-label, randomised, phase 3 trial by Bashir, Qaiser, Thall, Peter F, Milton, Denái R, Fox, Patricia S, Kawedia, Jitesh D, Kebriaei, Partow, Shah, Nina, Patel, Krina, Andersson, Borje S, Nieto, Yago L, Valdez, Ben C, Parmar, Simrit, Rondon, Gabriela, Delgado, Ruby, Hosing, Chitra, Popat, Uday R, Oran, Betul, Ciurea, Stefan O, Lin, Pei, Weber, Donna M, Thomas, Sheeba K, Lee, Hans C, Manasanch, Elisabet E, Orlowski, Robert Z, Williams, Loretta A, Champlin, Richard E, Qazilbash, Muzaffar H

“…Retrospective studies suggest that conditioning therapy with busulfan plus melphalan could result in longer progression-free survival compared with melphalan…”
Get full text

Prognostic value of disease distribution in secondary central nervous system diffuse large B cell lymphoma treated with radiation therapy by Al Feghali, Karine A., Fang, Penny, Gule-Monroe, Maria, Milgrom, Sarah, Khoury, Joseph D., Gunther, Jillian R., Sheu, Tommy, Nair, Ranjit, Ahmed, Sairah, Steiner, Raphael, Strati, Paolo, Shpall, Elizabeth J., Nieto, Yago L., Hosing, Chitra, Nastoupil, Loretta J., Westin, Jason R., Neelapu, Sattva S., Fowler, Nathan, Flowers, Christopher, Pinnix, Chelsea C., Dabaja, Bouthaina S.

“…This study aimed to assess the prognostic value of baseline disease distribution for patients with the secondary central nervous system (CNS) diffuse large…”
Get full text

Hitting a Moving Target: Successful Management of Diffuse Large B-cell Lymphoma Involving the Mesentery With Volumetric Image-guided Intensity Modulated Radiation Therapy by Yoder, Alison K., Gunther, Jillian R., Milgrom, Sarah A., Mirkovic, Dragan, Nastoupil, Loretta, Neelapu, Sattva, Fanale, Michelle, Fowler, Nathan, Westin, Jason, Lee, Hun Ju, Rodriguez, M.Alma, Iyer, Swaminathan P., Fayad, Luis, Nieto, Yago L., Hosing, Chitra, Ahmed, Sairah, Medeiros, L.Jeffrey, Khoury, Joseph D., Garg, Naveen, Amini, Behrang, Dabaja, Bouthaina S., Pinnix, Chelsea C.

“…Lymph nodes in the mesentery are a common location for non-Hodgkin lymphoma; however, there is often concern regarding the use of radiation therapy (RT) for…”
Get full text

The Histone Deacetylase Inhibitor SAHA Sensitizes Lymphoma Cells to Combination of Cladribine and Gemcitabine with DNA Alkylating Agent Busulfan by Ji, Jie, MD, Valdez, Ben C., PhD, Li, Yang, MS, Liu, Yan, Teo, Esmeralda C., MD, Nieto, Yago L., MD, PhD, Champlin, Richard E., MD, Andersson, Borje S., MD, PhD

Get full text

Autologous Hematopoietic Stem Cell Transplantation (Auto-HCT) for Multiple Myeloma (MM) in the Inpatient (Inpt) Vs. Outpatient (Outpt) Settings: Impact of Hematopoietic Stem Cell Comorbidity Index (HCT-CI) by Cornelison, A. Megan, MS, PA-C, Saliba, Rima, PhD, Ahmed, Sairah, Nieto, Yago L., MD, PhD, Bashir, Qaiser, MD, Shah, Nina, MD, Parmar, Simrit, MD, Hosing, Chitra, MD, Popat, Uday R., MD, Shpall, Elizabeth J., MD, Champlin, Richard E., MD, Qazilbash, Muzaffar H., MD

Get full text

A Randomized Phase III Trial of Busulfan + Melphalan Vs Melphalan Alone for Multiple Myeloma by Qazilbash, Muzaffar H., MD, Thall, Peter, PhD, Fox, Patricia S., MS, Kebriaei, Partow, MD, Bashir, Qaiser, MD, Shah, Nina, MD, Patel, Krina, MD, Andersson, Borje S., MD, PhD, Nieto, Yago L., MD, PhD, Valdez, Ben C., PhD, Parmar, Simrit, MD, Rondon, Gabriela, MD, Delgado, Ruby, Dinh, Yvonne, BS, Hosing, Chitra, MD, Popat, Uday R., MD, Lin, Pei, MD, Shah, Jatin, Orlowski, Robert Z., MD, Champlin, Richard E., MD

Get full text

Cytogenetics and Blast Count Determine Transplant Outcomes in Advanced AML by Popat, Uday R., MD, Saliba, Rima, PhD, Oran, Betul, MD, Chen, Julianne, BS, Alousi, Amin M., MD, Ahmed, Sairah, Bashir, Qaiser, MD, Ciurea, Stefan O., MD, Hosing, Chitra, MD, Jones, Roy B., MD, PhD, Kebriaei, Partow, MD, Khouri, Issa F., MD, Nieto, Yago L., MD, PhD, Olson, Amanda, M.D, Parmar, Simrit, MD, Shah, Nina, MD, Shpall, Elizabeth J., MD, Qazilbash, Muzaffar H., MD, Andersson, Borje S., MD, PhD, Champlin, Richard E., MD

Get full text

Combining AFM13, a bispecific CD30/CD16 antibody, with cytokine-activated cord blood-derived NK cells facilitates CAR-like responses against CD30+ malignancies by Kerbauy, Lucila N., Marin-Agudelo, Nancy, Kaplan, Mecit, Banerjee, Pinaki P., Berrien-Elliott, Melissa M., Becker-Hapak, Michelle, Basar, Rafet, Foster, Mark, Melo, Luciana Garcia, Neal, Carly, McClain, Ethan, Daher, May, Cortes, Ana Karen Nunez, Desai, Sweta, Lim, Francesca Wei Inng, Mendt, Mayela Carolina, Schappe, Timothy, Li, Li, Shaim, Hila, Shanley, Mayra, Ensley, Emily L., Uprety, Nadima, Wong, Pamela, Liu, Enli, Ang, Sonny O., Cai, Rong, Nandivada, Vandana, Mohanty, Vakul, Miao, Qi, Shen, Yifei, Baran, Natalia, Fowlkes, Natalie, Chen, Ken, Muniz-Feliciano, Luis, Champlin, Richard E., Nieto, Yago L., Koch, Joachim, Treder, Martin, Fischer, Wolfgang, Okamoto, Oswaldo Keith, Shpall, Elizabeth J., Fehniger, Todd A., Rezvani, Katayoun

Get full text

Hispanics have the Lowest Stem Cell Utilization Rate for Autologous Hematopoietic Cell Transplantation for Multiple Myeloma in the United States: a CIBMTR Report by Schriber, Jeffrey R, Hari, Parameswaran N, Ahn, Kwang Woo, Fei, Mingwei, Costa, Luciano J, Kharfan-Dabaja, Mohamad A, Angel-Diaz, Miguel, Gale, Robert P, Ganguly, Siddharatha, Girnius, Saulius K, Hashmi, Shahrukh, Pawarode, Attaphol, Vesole, David H, Wiernik, Peter H, Wirk, Baldeep M, Marks, David I, Nishihori, Taiga, Olsson, Richard F, Usmani, Saad Z, Mark, Tomer M, Nieto, Yago L, D’Souza, Anita

Get full text

Busulfan Plus Melphalan versus Melphalan Alone Conditioning Before Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: An Open-label, Randomized Phase III Trial by Bashir, Qaiser, Thall, Peter F., Milton, Denái R., Fox, Patricia S., Kawedia, Jitesh D, Kebriaei, Partow, Shah, Nina, Patel, Krina, Andersson, Borje S., Nieto, Yago L., Valdez, Ben C., Parmar, Simrit, Rondon, Gabriela, Delgado, Ruby, Hosing, Chitra, Popat, Uday R., Oran, Betul, Ciurea, Stefan O., Lin, Pei, Weber, Donna M., Thomas, Sheeba K., Lee, Hans C., Manasanch, Elisabet E., Orlowski, Robert Z., Williams, Loretta A., Champlin, Richard E., Qazilbash, Muzaffar H.

Get full text

Failure is not fatal: long-term remission in refractory acute myeloid leukemia (AML) after graft failure of cord blood stem cells by Burger, J A, Velev, N S, Jabbour, E J, Wierda, W G, Ravandi, F, Cortes, J E, Kantarjian, H, Nieto, Y L, Shpall, E J, Jorgensen, J L

Get full text